Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment [NA]
A clinical trial update describing a newly developed Optical Coherence Tomography (OCT) probe intended to improve bladder cancer diagnosis a…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating RC48 (disitamab vedotin) in combination with toripalimab as neoadjuvant therapy for cisplatin-ineligible muscle-i…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: The Supraspinal Control of Lower Urinary Tract Function in Patients with Orthotopic Sigmoid Neobladder.
A clinical trial is currently recruiting to investigate supraspinal control of lower urinary tract function in patients who have undergone o…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects [Phase 2]
Phase 2 neoadjuvant trial evaluating toripalimab in combination with gemcitabine and cisplatin for locally advanced bladder cancer; currentl…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer [Phase 2]
Phase 2 clinical trial evaluating cabozantinib in combination with atezolizumab for muscle-invasive bladder cancer; the study is currently a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer [NA]
A clinical trial is evaluating capsule-sparing cystectomy versus radical cystoprostatectomy in men with bladder cancer; the study is current…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating chidamide in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma. The study is c…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder [NA]
A clinical trial comparing safety and efficacy of Detaenial Sigmoid Neobladder versus Ileal Neobladder for bladder cancer requiring urinary …
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) [NA]
A clinical trial update for HIRACUM evaluating hypofractionated IMRT with concurrent chemotherapy in muscle-invasive bladder cancer, current…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors [NA]
The clinical trial compares bipolar en bloc resection versus Thulium-YAG en bloc resection for bladder tumors and is currently active but no…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer [NA]
SWOG's S1011 trial comparing standard versus extended pelvic lymphadenectomy in invasive bladder cancer completed. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma; resul…
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. [Phase 4]
A Phase 4 trial evaluating reinduction with Nadofaragene firadenovec in bladder cancer patients with CIS ± high-grade Ta/T1 and no complete …
-
CLINICAL_TRIALS other · 2024-11-19Clinical Trial Update: Better in Better Out Cystectomy.
This is a clinical trial update for NCT06694649, titled 'Better in Better Out Cystectomy,' studying bladder cancer. The study is not yet rec…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma [Phase 1]
Phase I/Ib trial assessing the combination of pembrolizumab with vorinostat in patients with advanced renal cell carcinoma or bladder cancer…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit [NA]
A completed clinical trial comparing intrathecal morphine versus continuous epidural analgesia to evaluate return of bowel function after la…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Mood Disorders Bladder Cancer
A clinical trial sponsored by the University of Kansas Medical Center for bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer [Phase 3]
Phase 3 clinical trial update on adjuvant intraarterial chemotherapy after surgery for locally advanced bladder cancer; the study has comple…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer [Phase 3]
Update on a Phase 3 single-arm trial of UGN-102 for low-grade, intermediate-risk non-muscle invasive bladder cancer; results were posted in …
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins
A Mansoura University trial is assessing whether a second transurethral resection for pT1 bladder cancer can be avoided after an initial en-…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Can VI-RADS/ADC Accurately Stage Bladder Cancer?? [NA]
This clinical trial update discusses evaluating VI-RADS/ADC imaging to stage bladder cancer, with the study currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 trial of CCT301-59 CAR T therapy in adults with recurrent or refractory solid tumors has been terminated. The study included soft ti…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
This document outlines a research protocol to evaluate the efficacy of perfused chemotherapeutic agents for bladder cancer using organoid te…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors [Phase 1, Phase 2]
Terminated basket trial evaluating Lerapolturev with or without checkpoint inhibitors in solid tumors, including bladder cancer and non-musc…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients
This completed clinical trial evaluated ENPP1 expression and the immune response in patients with bladder cancer.